When the Edinburgh cohort were identified as having been infected with HTLV-3 through the use of PFC products, it was discovered that 4,000 donors had contributed to the implicated batch.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Pool Sizes